AstraZeneca Vaccine almost powerless against South African coronavirus strain: Study
Feb 07, 2021, at 04:05 pm
London/Sputnik: The Oxford/AstraZeneca coronavirus vaccine only offers limited protection against the South African strain of the coronavirus, a study due to be released on Monday shows.
Vietnam approves AstraZeneca vaccine against COVID-19
Jan 30, 2021, at 10:07 pm
Bangkok/Sputnik: The Vietnamese authorities have approved the use of the AtraZeneca/Oxford University vaccine against COVID-19, the government news portal reported on Saturday.
AstraZeneca CEO says firm found 'Winning Formula' for vaccine against COVID-19
Dec 28, 2020, at 04:12 pm
Moscow/Sputnik: AstraZeneca has found a "winning formula" to boost the efficacy of its vaccine against COVID-19, which has been developed in conjunction with the University of Oxford, CEO Pascal Soriot told the UK's Sunday Times newspaper.
AstraZeneca's COVID-19 vaccine trial to resume in US
Oct 24, 2020, at 03:28 pm
Washington/Xinhua: Multinational pharmaceutical company AstraZeneca said on Friday it will resume the trial of its experimental COVID-19 vaccine in the United States, which has been paused since September.
Serum Institute gets DCGI nod to resume Covid-19 vaccine
Sep 16, 2020, at 04:25 pm
New Delhi/IBNS: The Serum Institute of India (SII) has got the nod of the Drug Controller General of India (DCGI) to resume the phase two and three trials for Covid-19 vaccine, media reports said.
India reports biggest daily spike in Covid-19 cases, adds over 95,000 infections in 24 hours
Sep 10, 2020, at 04:18 pm
New Delhi/IBNS: India, a country of 1.3 billion people, on Thursday reported the biggest daily spike by adding over 95,000 fresh infections in the last 24 hours.
After Oxford Covid-19 Vaccine trial pause, DCGI sends show-cause notice to Serum Institute
Sep 10, 2020, at 04:23 am
New Delhi/IBNS: After pharmaceutical giant AstraZeneca halted the Phase 3 study testing of the Oxford Vaccine against Covid-19, the Drugs Controller General of India (DCGI) on Wednesday issued a show-cause notice to Serum Institute of India (SII) for not informing the central drug regulator about the pause of trials in other countries.
AstraZeneca pauses Covid-19 vaccine trial after suspected adverse reaction seen in participant
Sep 09, 2020, at 01:30 pm
London: Pharmaceutical company AstraZeneca has halted the Phase 3 study testing of a Covid-19 vaccine after a suspected serious adverse reaction was seen in a participant in the United Kingdom, media reports said.
Jul 31, 2020, at 02:12 pm
Nirsevimab showed a significant reduction in medically-attended lower respiratory tract infections (LRTI) and hospitalisations caused by respiratory syncytial virus (RSV) in healthy preterm infants in a positive Phase IIb trial published in the New England Journal of Medicine.